Professor Martin Tobin is a Consultant in Public Health (Fellow of the Faculty of Public Health). He is a Fellow of the Academy of Medical Sciences, Professor of Genetic Epidemiology and Public Health at the University of Leicester, and Chair of the Leicester Precision Medicine Institute.
Since the COVID-19 pandemic, he has developed studies to improve understanding of the risk factors and consequences of COVID-19, and with local partners has designed a COVID-19 testing programme aiming to reduce viral transmission.
He leads a programme of research on the genomics of common, complex diseases to inform drug development and repositioning. His team’s research has defined the genetic variants associated with lung function and COPD. He established the first genetic study at the UK Biobank, and the resulting genetic data have led to many novel discoveries.
Professor Tobin has made national and international television appearances to increase public understanding of the risk of smoking - a key strategy in reducing smoking-related diseases.
He is Director for a PhD Programme in Genomic Epidemiology and Public Health Genomics at the University of Leicester, funded by the Wellcome Trust.
Get in touch for media enquiries, expert opinion, interviews, images or video.